Business
ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office
Utility Patent Covers the formulation for ELEVAI’s flagship exosome-based skin care products NEWPORT BEACH, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- ELEVAI
About this update from Pmgc Holdings Inc.
[{"type":"text","content":"Utility Patent Covers the formulation for ELEVAI’s flagship exosome-based skin care products\nNEWPORT BEACH, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- ELEVAI LABS, INC., (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, is pleased to announce today that the United States Patent & Trademark Office (USPTO) issued US Patent No. 11,878,038, entitled “Exosome-based Skincare Product” (the “Patent”) covering the primary formulation for ELEVAI’s exosome-based skin care products. The ELEVAI exosomes™ used in ELEVAI Labs’ formulations are derived from specially cultured and treated umbilical mesenchymal stem cells to generate a specific profile for the applications desired. ELEVAI’s enfinity™ and empower™ formulations are both covered by the Patent. “We are pleased the USPTO has issued this critical patent, which is the first step towards building ELEVAI’s patent moat in the aesthetics market. The Company will continue to strive to invent or acquire the best and most technically advanced products, which we believe will maintain ELEVAI’s competitive edge in the physician-dispensed skincare market and beyond,” said ELEVAI co-founder and CEO, Jordan R. Plews, PhD. About ELEVAI Labs ELEVAI Labs, Inc. (NASDAQ: ELAB) is a medical aesthetics company developing cutting-edge physician-dispensed skin care applications. The company solves unmet needs in the medical aesthetics space through a combination of cutting-edge science-driven and next-generation consumer applications. ELEVAI Labs develops topical aesthetic skin care cosmetic products for the physician-dispensed market, with a focus on leveraging a proprietary stem cell exosome technology. For more information visit www.elevaiskincare.com. Forward-Looking Statements Certain statements made in this press release are \"forward-looking statements'' within the meaning of the \"safe harbor\" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified using words such as \"anticipate\", \"believe\", \"expect\", \"estimate\", \"plan\", \"outlook\", and \"project\" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements reflect the current analysis of existing information and are subject to various risks a...